{"id":"https://openalex.org/W1992320105","doi":"https://doi.org/10.1097/00004714-200104000-00009","title":"Diphenhydramine Alters the Disposition of Venlafaxine Through Inhibition of CYP2D6 Activity in Humans","display_name":"Diphenhydramine Alters the Disposition of Venlafaxine Through Inhibition of CYP2D6 Activity in Humans","publication_year":2001,"publication_date":"2001-04-01","ids":{"openalex":"https://openalex.org/W1992320105","doi":"https://doi.org/10.1097/00004714-200104000-00009","mag":"1992320105","pmid":"https://pubmed.ncbi.nlm.nih.gov/11270914"},"language":"en","primary_location":{"id":"doi:10.1097/00004714-200104000-00009","doi":"https://doi.org/10.1097/00004714-200104000-00009","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004714-200104000-00009","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"\u00c9tienne Lessard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I43406934","display_name":"Universit\u00e9 Laval","ror":"https://ror.org/04sjchr03","country_code":"CA","type":"education","lineage":["https://openalex.org/I43406934"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"\u00c9tienne Lessard","raw_affiliation_strings":["Quebec Heart Institute, Laval Hospital, Canada","Pharmacy and \u2021Medicine, Laval University","Quebec Heart Institute, Laval Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quebec Heart Institute, Laval Hospital, Canada","institution_ids":[]},{"raw_affiliation_string":"Pharmacy and \u2021Medicine, Laval University","institution_ids":["https://openalex.org/I43406934"]},{"raw_affiliation_string":"Quebec Heart Institute, Laval Hospital","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016297281","display_name":"Marie\u2010Andr\u00e9e Yessine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I43406934","display_name":"Universit\u00e9 Laval","ror":"https://ror.org/04sjchr03","country_code":"CA","type":"education","lineage":["https://openalex.org/I43406934"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Marie-Andr\u00e9e Yessine","raw_affiliation_strings":["Pharmacy and \u2021Medicine, Laval University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy and \u2021Medicine, Laval University","institution_ids":["https://openalex.org/I43406934"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111775601","display_name":"Bettina A. Hamelin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I43406934","display_name":"Universit\u00e9 Laval","ror":"https://ror.org/04sjchr03","country_code":"CA","type":"education","lineage":["https://openalex.org/I43406934"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Bettina A. Hamelin","raw_affiliation_strings":["Pharmacy and \u2021Medicine, Laval University","Quebec Heart Institute, Laval Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy and \u2021Medicine, Laval University","institution_ids":["https://openalex.org/I43406934"]},{"raw_affiliation_string":"Quebec Heart Institute, Laval Hospital","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107196993","display_name":"Caroline Gauvin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I43406934","display_name":"Universit\u00e9 Laval","ror":"https://ror.org/04sjchr03","country_code":"CA","type":"education","lineage":["https://openalex.org/I43406934"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Caroline Gauvin","raw_affiliation_strings":["Pharmacy and \u2021Medicine, Laval University","Quebec Heart Institute, Laval Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy and \u2021Medicine, Laval University","institution_ids":["https://openalex.org/I43406934"]},{"raw_affiliation_string":"Quebec Heart Institute, Laval Hospital","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063812511","display_name":"Line Labb\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I43406934","display_name":"Universit\u00e9 Laval","ror":"https://ror.org/04sjchr03","country_code":"CA","type":"education","lineage":["https://openalex.org/I43406934"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Line Labb\u00e9","raw_affiliation_strings":["Pharmacy and \u2021Medicine, Laval University","Quebec Heart Institute, Laval Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy and \u2021Medicine, Laval University","institution_ids":["https://openalex.org/I43406934"]},{"raw_affiliation_string":"Quebec Heart Institute, Laval Hospital","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011647323","display_name":"Gilles E O\u2019Hara","orcid":"https://orcid.org/0000-0002-1115-8108","observed_orcids":["https://orcid.org/0000-0002-1115-8108"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Gilles O'Hara","raw_affiliation_strings":["Quebec Heart Institute, Laval Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quebec Heart Institute, Laval Hospital","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069797338","display_name":"Jacynthe LeBlanc","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121083","display_name":"Institut Universitaire en Sant\u00e9 Mentale de Qu\u00e9bec","ror":"https://ror.org/03mt5nv96","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801902503","https://openalex.org/I4210121083","https://openalex.org/I4210139015","https://openalex.org/I4392738268","https://openalex.org/I4405279980"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Jacynthe LeBlanc","raw_affiliation_strings":["Department of Pharmacy, Robert Giffard Hospital Center, Qu\u00e9bec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Robert Giffard Hospital Center, Qu\u00e9bec, Canada","institution_ids":["https://openalex.org/I4210121083"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080359453","display_name":"Jacques Turgeon","orcid":"https://orcid.org/0000-0002-7978-9280","observed_orcids":["https://orcid.org/0000-0002-7978-9280"]},"institutions":[{"id":"https://openalex.org/I43406934","display_name":"Universit\u00e9 Laval","ror":"https://ror.org/04sjchr03","country_code":"CA","type":"education","lineage":["https://openalex.org/I43406934"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Jacques Turgeon","raw_affiliation_strings":["Pharmacy and \u2021Medicine, Laval University","Quebec Heart Institute, Laval Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy and \u2021Medicine, Laval University","institution_ids":["https://openalex.org/I43406934"]},{"raw_affiliation_string":"Quebec Heart Institute, Laval Hospital","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5011647323","https://openalex.org/A5063812511","https://openalex.org/A5080359453","https://openalex.org/A5107196993","https://openalex.org/A5111775601"],"corresponding_institution_ids":["https://openalex.org/I43406934"],"apc_list":null,"apc_paid":null,"fwci":2.7612,"has_fulltext":false,"cited_by_count":92,"citation_normalized_percentile":{"value":0.89683822,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"21","issue":"2","first_page":"175","last_page":"184"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diphenhydramine","display_name":"diphenhydramine","score":0.9929999709129333},{"id":"https://openalex.org/keywords/venlafaxine","display_name":"venlafaxine","score":1.0},{"id":"https://openalex.org/keywords/cyp2d6-inhibition","display_name":"CYP2D6 inhibition","score":0.953000009059906},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8650000095367432},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.5120000243186951},{"id":"https://openalex.org/keywords/oral-clearance","display_name":"oral clearance","score":0.7480000257492065},{"id":"https://openalex.org/keywords/antidepressant-metabolism","display_name":"antidepressant metabolism","score":0.46399998664855957},{"id":"https://openalex.org/keywords/antihistamines","display_name":"antihistamines","score":0.5839999914169312}],"concepts":[{"id":"https://openalex.org/C2781292560","wikidata":"https://www.wikidata.org/wiki/Q413486","display_name":"Diphenhydramine","level":3,"score":0.875006914138794},{"id":"https://openalex.org/C2776466888","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine","level":4,"score":0.8378704190254211},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7328391075134277},{"id":"https://openalex.org/C33664856","wikidata":"https://www.wikidata.org/wiki/Q3271142","display_name":"CYP2D6","level":4,"score":0.6875134110450745},{"id":"https://openalex.org/C2776880894","wikidata":"https://www.wikidata.org/wiki/Q324089","display_name":"Antihistamine","level":2,"score":0.5942896008491516},{"id":"https://openalex.org/C2909532165","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine Hydrochloride","level":5,"score":0.5893076658248901},{"id":"https://openalex.org/C97320921","wikidata":"https://www.wikidata.org/wiki/Q718753","display_name":"Drug interaction","level":3,"score":0.5780776739120483},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.5085490942001343},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.48769888281822205},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.44655951857566833},{"id":"https://openalex.org/C2910046258","wikidata":"https://www.wikidata.org/wiki/Q413486","display_name":"Diphenhydramine hydrochloride","level":4,"score":0.4391748607158661},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4341368079185486},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.42582952976226807},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2921750545501709},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28708988428115845},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.221854567527771},{"id":"https://openalex.org/C1122143","wikidata":"https://www.wikidata.org/wiki/Q61233","display_name":"Histamine","level":2,"score":0.15321654081344604},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.1445423662662506},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.14425525069236755},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069470","descriptor_name":"Venlafaxine Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000704","descriptor_name":"Analysis of Variance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003511","descriptor_name":"Cyclohexanols","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003511","descriptor_name":"Cyclohexanols","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004155","descriptor_name":"Diphenhydramine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006634","descriptor_name":"Histamine H1 Antagonists","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010641","descriptor_name":"Phenotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019389","descriptor_name":"Cytochrome P-450 CYP2D6","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D065690","descriptor_name":"Cytochrome P-450 CYP2D6 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004714-200104000-00009","doi":"https://doi.org/10.1097/00004714-200104000-00009","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004714-200104000-00009","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:11270914","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11270914","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307845","display_name":"Heart and Stroke Foundation of Canada","ror":"https://ror.org/00qbpyp73"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W43359458","https://openalex.org/W58792551","https://openalex.org/W203197107","https://openalex.org/W1540726821","https://openalex.org/W1966497539","https://openalex.org/W1970421748","https://openalex.org/W1970846917","https://openalex.org/W1971544024","https://openalex.org/W1975507504","https://openalex.org/W1975588016","https://openalex.org/W1979293025","https://openalex.org/W1984850614","https://openalex.org/W1984924550","https://openalex.org/W1986242073","https://openalex.org/W1992938026","https://openalex.org/W2003017820","https://openalex.org/W2003741490","https://openalex.org/W2008227100","https://openalex.org/W2012610108","https://openalex.org/W2016911934","https://openalex.org/W2017051912","https://openalex.org/W2023210123","https://openalex.org/W2025111977","https://openalex.org/W2036548290","https://openalex.org/W2037085702","https://openalex.org/W2066806870","https://openalex.org/W2075241989","https://openalex.org/W2076663194","https://openalex.org/W2078775644","https://openalex.org/W2081842637","https://openalex.org/W2084497711","https://openalex.org/W2131528170","https://openalex.org/W2145055984","https://openalex.org/W2156412357","https://openalex.org/W2396891752","https://openalex.org/W2403653179","https://openalex.org/W2411787213","https://openalex.org/W2411914681","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2019665976","https://openalex.org/W2167690131","https://openalex.org/W2054870673","https://openalex.org/W2396891752","https://openalex.org/W2046420852","https://openalex.org/W2003017820","https://openalex.org/W2057098692","https://openalex.org/W2023765120","https://openalex.org/W7155055594","https://openalex.org/W2084497711"],"abstract_inverted_index":{"CYP2D6":[0,15,45,197],"is":[1],"the":[2,7,48,67,74,104,224],"major":[3],"enzyme":[4],"involved":[5],"in":[6,34,51,174,215],"metabolism":[8,212],"of":[9,21,79,107,167,181,202,213,227,238],"venlafaxine.":[10,61,203],"Subjects":[11],"with":[12,66,73],"a":[13,40,54],"low":[14,196],"activity":[16,198],"have":[17],"increased":[18],"plasma":[19],"concentrations":[20],"venlafaxine":[22,82,131,155,161,182,214],"that":[23,38,235],"may":[24],"predispose":[25],"them":[26],"to":[27,137,183],"cardiovascular":[28],"side":[29],"effects.":[30],"In":[31,127,164,204],"vitro":[32],"and":[33,60,71,101,116,157,177,229],"vivo":[35],"studies":[36],"showed":[37],"diphenhydramine,":[39,206],"nonprescription":[41],"antihistamine,":[42],"can":[43],"inhibit":[44],"activity.":[46],"Therefore,":[47],"authors":[49],"investigated":[50],"this":[52],"study":[53],"potential":[55],"drug":[56],"interaction":[57],"between":[58],"diphenhydramine":[59,108,129,168,228],"Fifteen":[62],"male":[63],"volunteers,":[64],"nine":[65],"extensive":[68],"metabolizer":[69,76],"(EM)":[70],"six":[72],"poor":[75],"(PM)":[77],"phenotype":[78],"CYP2D6,":[80],"received":[81],"hydrochloride":[83,109],"18.75":[84],"mg":[85,111],"orally":[86],"every":[87,112],"12":[88,113,122],"hours":[89,92,123],"for":[90,121],"48":[91],"on":[93,149],"two":[94],"occasions":[95],"(1":[96],"week":[97],"apart):":[98],"once":[99,102],"alone":[100,156],"during":[103,154,160,223],"concomitant":[105,200,225],"administration":[106,201,226],"(50":[110],"hours).":[114],"Blood":[115],"urine":[117],"samples":[118],"were":[119],"collected":[120],"under":[124],"steady-state":[125],"conditions.":[126],"EMs,":[128],"decreased":[130],"oral":[132,175],"clearance":[133,151,176],"from":[134],"104+/-60":[135],"L/hr":[136,139,153,159],"43+/-23":[138],"(mean":[140],"+/-":[141],"SD;":[142],"p":[143],"<":[144],"0.05)":[145],"without":[146],"any":[147],"effect":[148],"renal":[150],"(4+/-1":[152],"4+/-2":[158],"plus":[162],"diphenhydramine).":[163],"PMs,":[165],"coadministration":[166],"did":[169],"not":[170],"cause":[171],"significant":[172,218],"changes":[173],"partial":[178],"metabolic":[179],"clearances":[180],"its":[184],"various":[185],"metabolites.":[186],"Diphenhydramine":[187],"disposition":[188],"was":[189],"only":[190],"slightly":[191],"affected":[192],"by":[193],"genetically":[194],"determined":[195],"or":[199,232],"conclusion,":[205],"at":[207],"therapeutic":[208],"doses,":[209],"inhibits":[210],"CYP2D6-mediated":[211],"humans.":[216],"Clinically":[217],"interactions":[219],"could":[220],"be":[221],"encountered":[222],"other":[230],"antidepressant":[231],"antipsychotic":[233],"drugs":[234],"are":[236],"substrates":[237],"CYP2D6.":[239]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":6},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}